TherapeuticsMD, Inc.
TherapeuticsMD, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2013, the company focuses on developing innovative products for women's health, particularly in hormone therapy and contraception. With a commitment to addressing unmet medical needs, TherapeuticsMD has achieved significant milestones, including the launch of its flagship products, which are designed to enhance the quality of life for women. The company’s core offerings include hormone replacement therapies and contraceptive solutions that stand out due to their unique formulations and delivery methods. TherapeuticsMD is recognised for its dedication to research and development, positioning itself as a leader in the women's health sector. With a growing portfolio and a focus on patient-centric solutions, TherapeuticsMD continues to make strides in improving healthcare outcomes for women across the globe.
DitchCarbon Score
How does TherapeuticsMD, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TherapeuticsMD, Inc.'s score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TherapeuticsMD, Inc.'s reported carbon emissions
TherapeuticsMD, Inc., headquartered in the US, currently does not have available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no reported Scope 1, 2, or 3 emissions for the most recent year. Additionally, the company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. This lack of data suggests that TherapeuticsMD, Inc. may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it is essential for TherapeuticsMD, Inc. to consider setting measurable climate commitments and reduction targets to align with global efforts in mitigating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TherapeuticsMD, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
